Ultragenyx Pharmaceutical | RARE - Market Capitalization


Ultragenyx Pharmaceutical reported $1.87B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Agios Pharmaceuticals USD 1.6B 16M Feb/2026
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
BioCryst Pharmaceuticals USD 1.23B 115M Dec/2023
BioMarin Pharmaceutical USD 11.99B 575M Feb/2026
Esperion Therapeutics USD 340M 235M Dec/2023
Immunic USD 68M 2M Dec/2023
Insmed USD 23.91B 13.21B Feb/2026
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Kyowa Hakko Kirin JPY 1.36T 28.23B Feb/2026
MacroGenics USD 114M 8M Feb/2026
Moderna USD 16.5B 6.41B Feb/2026
Neurocrine Biosciences USD 13.68B 465M Feb/2026
PTC Therapeutics USD 5.36B 744M Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Ultragenyx Pharmaceutical USD 1.94B 284M Feb/2026
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026
Xoma USD 162M 55M Sep/2023